Charles River Laboratories CRL Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $8.49B.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's market capitalization?
- Charles River Laboratories (CRL) reported market capitalization of $8.49B in Q1 2026.
- How has Charles River Laboratories's market capitalization changed year-over-year?
- Charles River Laboratories's market capitalization increased by 10.3% year-over-year, from $7.7B to $8.49B.
- What is the long-term trend for Charles River Laboratories's market capitalization?
- Over 5 years (2020 to 2025), Charles River Laboratories's market capitalization has grown at a -4.9% compound annual growth rate (CAGR), from $12.61B to $9.82B.
- What does market capitalization mean?
- What the stock market says the company's equity is worth.
- How do you interpret market capitalization?
- A size and market-sentiment gauge, not a quality measure — interpret through valuation ratios (P/E, P/S) that relate it to fundamentals.
- How does market capitalization compare across companies?
- Comparable across companies as a size class; the input to every equity-price valuation multiple.